Pure Global AI
NCT06402812Completed

The Perceived Mismatch Between Dose Recommendations of PKI's and the Clinical Practice

University Medical Center GroningenClinicalTrials.govother
Verified
Study focus
Disease/Condition
Cancer
Drug/Device/Intervention
Interview
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University Medical Center Groningen
Location
Groningen, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Feb 06, 2024
End date
Mar 01, 2024
Enrollment
18 participants
Primary outcome

Interview

Summary

A qualitative research study will be conducted using semi-structured interviews. The target
 population includes regulators involved in the registration of PKIs and healthcare
 professionals who use PKIs in clinical practice. Participants will be recruited until a rich
 understanding of the subject is reached.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06402812
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06402812 through Pure Global AI's free database. This phase not specified trial is sponsored by University Medical Center Groningen and is currently Completed. The study focuses on Cancer. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.